The emerging role of Janus kinase inhibitors in the treatment of autoimmune and inflammatory diseases

W Damsky, D Peterson, J Ramseier… - Journal of Allergy and …, 2021 - Elsevier
Autoimmune and inflammatory diseases are common and diverse, and they can affect
nearly any organ system. Much of the pathogenesis of these diseases is related to …

[HTML][HTML] Suppl 2: JAK kinases in health and disease: an update

A Laurence, M Pesu, O Silvennoinen… - The open rheumatology …, 2012 - ncbi.nlm.nih.gov
Janus kinases (Jaks) are critical signaling elements for a large subset of cytokines. As a
consequence they play pivotal roles in the patho-physiology of many diseases including …

JAK inhibition as a therapeutic strategy for immune and inflammatory diseases

DM Schwartz, Y Kanno, A Villarino, M Ward… - Nature reviews Drug …, 2017 - nature.com
The discovery of cytokines as key drivers of immune-mediated diseases has spurred efforts
to target their associated signalling pathways. Janus kinases (JAKs) are essential signalling …

Discovery and development of Janus Kinase (JAK) inhibitors for inflammatory diseases: Miniperspective

JD Clark, ME Flanagan, JB Telliez - Journal of medicinal chemistry, 2014 - ACS Publications
The Janus kinases (JAKs) are a family of intracellular tyrosine kinases that play an essential
role in the signaling of numerous cytokines that have been implicated in the pathogenesis of …

[HTML][HTML] JAK inhibitors and autoimmune rheumatic diseases

M Benucci, P Bernardini, C Coccia, R De Luca… - Autoimmunity …, 2023 - Elsevier
The four Janus kinase (JAK) proteins and the seven Signal Transducers of Activated
Transcription (STAT) mediate intracellular signal transduction downstream of cytokine …

Type I/II cytokines, JAKs, and new strategies for treating autoimmune diseases

DM Schwartz, M Bonelli, M Gadina… - Nature Reviews …, 2016 - nature.com
Cytokines are major drivers of autoimmunity, and biologic agents targeting cytokines have
revolutionized the treatment of immune-mediated diseases. Despite the effectiveness of …

JAK inhibitors: Ten years after

FR Spinelli, F Meylan, JJ O'Shea… - European Journal of …, 2021 - Wiley Online Library
Abstract The European Journal of Immunology was launched 50 years ago, coinciding with
the discovery of many cytokines and growth factors and the emergence of an entirely new …

Selective Janus kinase inhibitors come of age

JJ O'Shea, M Gadina - Nature Reviews Rheumatology, 2019 - nature.com
Janus kinase (JAK) inhibitors (jakinibs) that target downstream signalling by a large range of
cytokines are effective in treating autoimmune and rheumatic diseases. Newer jakinibs that …

Janus kinase-targeting therapies in rheumatology: a mechanisms-based approach

Y Tanaka, Y Luo, JJ O'Shea… - Nature Reviews …, 2022 - nature.com
The four Janus kinase (JAK) proteins and seven signal transducer and activator of
transcription (STAT) transcription factors mediate intracellular signal transduction …

Janus kinases to jakinibs: from basic insights to clinical practice

M Gadina, MT Le, DM Schwartz, O Silvennoinen… - …, 2019 - academic.oup.com
Cytokines are critical mediators of diverse immune and inflammatory diseases. Targeting
cytokines and cytokine receptors with biologics has revolutionized the treatment of many of …